These agents mitigate muscle atrophy by downregulating atrophy-related factors (myostatin, MuRF1, MAFbx) and upregulating myogenic transcription factors (MyoD, MyoG) via PKA/Akt/mTOR signaling
One key factor is the expertise and reputation of our experienced medical providers
Pituitary, 27 (5), 731736
Market Segmentation Drug Type Insights (Revenue, USD BN, 2021 - 2033) Exenatide Liraglutide Sitagliptin Saxagliptin Alogliptin Others Disease Indication Insights (Revenue, USD BN, 2021 - 2033) Type 2 Diabetes Mellitus (T2DM) Weight Management Others Distribution Channel Insights (Revenue, USD BN, 2021 - 2033) Online Pharmacies Retail Pharmacies Hospital Pharmacies Regional Insights (Revenue, USD BN, 2021 - 2033) North America U.S
Your provider can evaluate your health history and prescribe the most appropriate, cost-effective, and FDA-approved medication for your specific needs
These medications are not appropriate for patients with certain medical conditions, which are assessed during your consultation